RESUMO
The present study examines the histological features of the lungs of neonates who died of respiratory distress syndrome or related complications after surfactant therapy. Our aim was to determine whether these lungs showed any unusual histological findings. Complete autopsies were performed 6-12 h after death in 10 surfactant-treated preterm infants and in 30 infants who died before surfactant therapy was available. Representative paraffin sections of all pulmonary lobes, stained with haematoxylin and eosin, were examined microscopically. A few selected slides were also stained with periodic acid-Schiff, Vierhoff-van Gieson, and Mallory trichrome. Hyaline membrane disease and bronchopulmonary dysplasia were present in each group, although there was an increased incidence of intra-alveolar haemorrhage in surfactant-treated babies (in 8 of 10 surfactant-treated as compared with 7 of 30 untreated babies). Amongst those treated with surfactant, we observed the persistence of acute alveolar damage with unresolved hyaline membrane disease in 5 infants who died at the ages of 5, 6, 10, 12, and 13 days, respectively, and histological evidence of pneumocyte type 2 hyperplasia and dysplasia in 2 infants who died at 22 and 41 days of age, respectively. These observations reveal that surfactant-treated infants who fail to respond to therapy have continuing alveolar injury and an increased incidence of intra-alveolar haemorrhage. Since oxygen radicals can induce pneumocyte damage and necrosis and since free radicals provoke alveolar haemorrhage in animal models, we propose that the lesions we observed may stem from a lack, in some preterm babies, of specific mechanisms that detoxify oxygen radicals.
Assuntos
Recém-Nascido Prematuro , Pulmão/patologia , Surfactantes Pulmonares/uso terapêutico , Síndrome do Desconforto Respiratório do Recém-Nascido/tratamento farmacológico , Síndrome do Desconforto Respiratório do Recém-Nascido/patologia , Displasia Broncopulmonar/induzido quimicamente , Displasia Broncopulmonar/patologia , Evolução Fatal , Feminino , Idade Gestacional , Hemorragia/induzido quimicamente , Hemorragia/patologia , Humanos , Doença da Membrana Hialina/induzido quimicamente , Doença da Membrana Hialina/patologia , Recém-Nascido , Pneumopatias/induzido quimicamente , Pneumopatias/patologia , Masculino , Alvéolos Pulmonares/patologiaRESUMO
Lung injury induced by 100% O2 over 6 days is characterized by markedly less alveolar fibrin and rare hyaline membranes in premature versus adult baboons. To determine the mechanism(s) underlying alveolar fibrin deposition in the evolution of hyaline membrane disease (HMD) through diffuse alveolar damage (DAD) and bronchopulmonary dysplasia (BPD), we measured procoagulant and fibrinolytic activities in lung lavage of premature baboons with HMD, those treated with 100% O2 for 6 days (DAD) or for 7 days followed by 14 days 80% O2 (BPD). Lavage procoagulant activity, mainly due to tissue factor associated with Factor VII, was increased by hyperoxia. Plasminogen-dependent fibrinolytic activity, due to both tissue plasminogen activator and urokinase, was stable or increased after hyperoxia. Plasminogen activator inhibitor 1 (PAI-1) was detectable in lavage of animals with HMD but not those with evolving DAD or BPD. Antiplasmin activity was stable or decreased. Although plasminogen was undetectable in lavage, D-dimer was increased in lavage of the groups exposed to hyperoxia versus HMD. The defect in plasminogen activator activity in lavage fluids of adult baboons with DAD induced by O2 does not occur in premature baboons with HMD, evolving DAD, or BPD. Expression of fibrinolytic activity in the lower respiratory tract of premature baboons is dependent on local access to plasminogen, which is present in relatively low concentrations in plasma of these animals.
Assuntos
Líquido da Lavagem Broncoalveolar/química , Displasia Broncopulmonar/metabolismo , Displasia Broncopulmonar/patologia , Fibrina/análise , Fibrina/metabolismo , Fibrinólise , Doença da Membrana Hialina/metabolismo , Doença da Membrana Hialina/patologia , Fatores Etários , Análise de Variância , Animais , Animais Recém-Nascidos , Displasia Broncopulmonar/etiologia , Fator VII/análise , Humanos , Doença da Membrana Hialina/induzido quimicamente , Doença da Membrana Hialina/complicações , Recém-Nascido , Masculino , Oxigênio , Papio , Inibidor 1 de Ativador de Plasminogênio/análise , Respiração Artificial/efeitos adversos , Ativador de Plasminogênio Tecidual/farmacologia , Ativador de Plasminogênio Tipo Uroquinase/farmacologiaRESUMO
Previously we have shown that a group of patients treated for iron overdose with prolonged deferoxamine (DFO) infusion died of adult respiratory distress syndrome (ARDS). We now describe a model to investigate the mechanism of this pulmonary toxicity. Mice treated with 1 oral dose of iron (Fe) and then multiple injections of DFO, or with the chelated product ferrioxamine alone, did not develop lung lesions, even at doses which induced mortality. To potentiate any possible free radical reaction, other groups of mice were treated similarly while exposed to 75-80% O2 over a 4-day period. Ten of 12 mice receiving 0.75 mg Fe and then DFO (10 mg, 4 times/day for 4 days) with hyperoxia died suddenly. At autopsy the lungs were dark red and solid; sections showed hyaline membranes and alveolar exudates of edema, fibrin, and PMN. Electron microscopy showed massive destruction of the alveolar epithelium; using cerium chloride, a free radical reaction product was demonstrated at the alveolar surface. Lung lavage fluid contained 10-12 x normal levels of protein when the Fe-DFO-O2 group was compared to air or O2 controls. Mice receiving DFO or Fe, plus O2, showed only slight injury and a small increase in alveolar protein. The results indicate that Fe plus DFO generates free radicals in the lung, a reaction potentiated by hyperoxia to produce an ARDS-like picture. This suggests that the pulmonary toxicity of DFO in iron-poisoned patients is due to its prooxidant activity resulting in free radical destruction of the airblood barrier.
Assuntos
Desferroxamina/toxicidade , Pneumopatias/induzido quimicamente , Pneumopatias/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Animais , Câmaras de Exposição Atmosférica , Líquido da Lavagem Broncoalveolar/metabolismo , Líquido da Lavagem Broncoalveolar/patologia , Modelos Animais de Doenças , Feminino , Compostos Férricos/toxicidade , Radicais Livres/metabolismo , Humanos , Doença da Membrana Hialina/induzido quimicamente , Doença da Membrana Hialina/metabolismo , Doença da Membrana Hialina/patologia , Recém-Nascido , Ferro/toxicidade , Quelantes de Ferro/toxicidade , Pneumopatias/patologia , Camundongos , Camundongos Endogâmicos , Microscopia Eletrônica , Oxigênio/administração & dosagem , Oxigênio/metabolismoRESUMO
The intraperitoneal administration of methylcyclopentadienyl manganese tricarbonyl (MMT) and cyclophosphamide, exposure to an aerosol of cadmium chloride, intravenous administration of oleic acid, and intratracheal instillation of bleomycin to young female BALB/c mice or CD/CR rats result in acute lung injury. Pulmonary morphology and lung collagen content were examined in animals treated with these chemicals alone or in combination with an elevated oxygen concentration (80%) in the inspired air. In mice, the development of fibrosis could be significantly enhanced if animals treated with MMT, cadmium chloride, cyclophosphamide, or bleomycin were exposed to 80% oxygen immediately following exposure to these agents. In rats only cyclophosphamide- and bleomycin-induced acute lung injury was potentiated by hyperoxia, resulting in significant enhancement of lung collagen content. The pathogenesis responsible for this differential species response of pulmonary injury to hyperoxia remains to be investigated.
Assuntos
Antineoplásicos/toxicidade , Cádmio/toxicidade , Pulmão/efeitos dos fármacos , Intoxicação por Manganês , Ácidos Oleicos/toxicidade , Compostos Organometálicos/toxicidade , Oxigênio/toxicidade , Animais , Bleomicina/toxicidade , Hidroxitolueno Butilado/toxicidade , Cloreto de Cádmio , Ciclofosfamida/toxicidade , Sinergismo Farmacológico , Feminino , Humanos , Doença da Membrana Hialina/induzido quimicamente , Hidroxiprolina/análise , Recém-Nascido , Pulmão/análise , Camundongos , Camundongos Endogâmicos BALB C , Ratos , Ratos Endogâmicos , Especificidade da EspécieRESUMO
Histological and electron-microscopic study of the lungs of 15 patients who had been treated with bleomycin for advanced squamous cell carcinoma demonstrated marked histological changes in nine. They were typical of bleomycin effects: alveolitis, intra-alveolar and interstitial oedema, pulmonary hyaline membranes, disseminated intravascular coagulation, intraalveolar and interstitial fibrosis, atelectasis, metaplasia and dysplasia of the alveolar lining cells. These lesions had a focal distribution, preferentially in the subpleural and periseptal regions. Each of these lesions alone is a non-characteristic reaction, but their combination makes it a distinct entity (bleomycin lung). Three different clinical courses were noted: (1) cases with no or little abnormality; (2) acute form during or shortly after bleomycin treatment; (3) chronic, progressive form of bleomycin lung which may end fatally as late as 1 1/2 years after bleomycin treatment had been discontinued. Squamous cell metaplasia is the most characteristic sign of bleomycin lung. It should not be confused with pulmonary metastases. To prove the diagnosis of bleomycin lung often requires systematic histological investigation. A schema of the pathogenesis of the bleomycin lung is proposed in which the formation of microthrombi plays an important part.